Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENaC as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes

NCT01804777 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.

NCT NCT01804777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01804777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENaC as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes
Lead sponsor
University of New Mexico
Phase
Phase 1
Overall status
Terminated
Start date
March 31, 2013
Completion date
December 31, 2014
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, proteinuria, type ii diabetes